On October 28, 2022, Impactive Capital LP announced that as of October 24, 2022, it has ceased to beneficially own more than 5% of the outstanding shares of Meridian Bioscience, Inc. Hence, the campaign is deemed to be withdrawn.
Meridian Bioscience, Inc.
Equities
VIVO
US5895841014
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-4.88% | 179B | |
+4.04% | 113B | |
-3.38% | 67.88B | |
+5.29% | 52.03B | |
+5.66% | 43.3B | |
+4.03% | 41.79B | |
+24.15% | 32.49B | |
+14.00% | 25.65B | |
-4.10% | 24.55B |